We use a range of cookies to give you the best possible browsing experience. By continuing to use this website, you agree to our use of cookies.
You can learn more about our cookie policy here, or by following the link at the bottom of any page on our site.

Free Trading Guides
EUR/USD
Mixed
Low
High
of clients are net long.
of clients are net short.
Long Short

Note: Low and High figures are for the trading day.

Data provided by
Oil - US Crude
Mixed
Low
High
of clients are net long.
of clients are net short.
Long Short

Note: Low and High figures are for the trading day.

Data provided by
Wall Street
Mixed
Low
High
of clients are net long.
of clients are net short.
Long Short

Note: Low and High figures are for the trading day.

Data provided by
Gold
Mixed
GBP/USD
Mixed
USD/JPY
Mixed
Low
High
of clients are net long.
of clients are net short.
Long Short

Note: Low and High figures are for the trading day.

Data provided by
More View more
EURUSD: Hold Short as Prices Probe 1.22 Mark

EURUSD: Hold Short as Prices Probe 1.22 Mark

2012-07-13 10:10:00
Ilya Spivak, Head Strategist, APAC
Share:

Strategy: Short at 1.2595, Targeting 1.2130

Floating Profit / Loss: +397 pips

We re-entered short EURUSD at 1.2595. Prices have now overcome our second target at 1.2364 and we have moved our stop-loss to breakeven, set to be triggered on a daily close above 1.2595. The next downside objective is 1.2130, the 61.8% Fibonacci expansion. Near-term resistance lines up at 1.2249, the 50% level.

EURUSD_Hold_Short_as_Prices_Probe_1.22_Mark_body_eurusd.png, EURUSD: Hold Short as Prices Probe 1.22 Mark

Daily Chart - Created Using FXCM Marketscope 2.0

--- Written by Ilya Spivak, Currency Strategist for Dailyfx.com

To contact Ilya, e-mail ispivak@dailyfx.com. Follow Ilya on Twitter at @IlyaSpivak

To be added to Ilya's e-mail distribution list, send a note with subject line "Distribution List" to ispivak@dailyfx.com

DailyFX provides forex news and technical analysis on the trends that influence the global currency markets.

DISCLOSURES

News & Analysis at your fingertips.